Sanuwave health targets 40%-50% Q2 revenue growth with strategic customer focus

Stock Information for SANUWAVE Health Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About SANUWAVE Health Inc.

Sanuwave to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO), iSupply
Sanuwave Announces Q3 FY2025 Financial Results
Sanuwave Will Host a Conference Call on November 7, 2025 at 8:30 AM (ET) to Present Q3 2025 Financial Results
CMS Publishes Final Rule for Calendar Year 2026 Physician Fee Schedule for UltraMIST Procedure (CPT code 97610)
Sanuwave Health Announces Preliminary Revenue Results for the Third Quarter 2025 (Ended September 30, 2025)
Sanuwave Announces Strategic Debt Refinancing with New Credit Facility
Sanuwave Announces Q2 FY2025 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.